arrow
返回
钱

钱锋 (Feng Qian)

Tsinghua University

36H指数
149论文数
5.3K被引数
收录论文 56
发表时间
Does expansion of clinical trial capacity improve healthcare access?临床 trial capacity 扩展是否能改善医疗保健可及性?
err2026-09-25
err0
PREAI
errYang Liu; Yuzi You; Cheng Li; Chenghao Ge; Yale Jiang; Sen Liu; Yusu Jian; Xin Wang; Yunhe Qin; Jianhua Jiang; Ying Gong; Haiyan Li; Jian Wu; Feng Qian; Fanpu Kong; Tien Yin Wong; Xiaoyuan Chen
err分享
err收藏
err分享
err收藏
Supramolecular Self-Assembled Multivalent Anti-VEGF Protein Nanospheres for Prolonged Ocular Retention超分子自组装多价抗VEGF蛋白纳米球用于延长眼内滞留时间
errSmall
IF12.1
err2025-11-28
err0
PREAI
errZhou Tian; Jingyuan Yang; Xuling Jiang; Jie Ma; Nien Li; Jiaqi Zhang; Jinliang Huang; Huiqin Liu; Youxin Chen; Feng Qian
err分享
err收藏
Surface Charge and Solvent Exposure Dictate the pH-Dependent Viscosity of Therapeutic Antibodies
err2025-11-01
err0
PREAI
errJiang, Xuling; Tian, Zhou; Chen, Zhidong; Yu, Xiaojuan; Yu, Chuanfei; Qian, Feng
err分享
err收藏
Olfactory receptors and human diseases嗅觉受体与人类疾病
err2025-04-25
err0
PREAI
errZhong-Qi Yuan; Xiao-Chun Peng; Lian Liu; Fu-Yuan Yang; Feng Qian
err分享
err收藏
Modulating the complement system through epitope-specific inhibition by complement C3 inhibitors
err2025-03-01
err0
errOAAI
errChen, Zhidong; Wang, Mingshuang; Duan, Wenqian; Xia, Yi; Liu, Huiqin; Qian, Feng
err分享
err收藏
A bioengineered anti-VEGF protein with high affinity and high concentration for intravitreal treatment of wet age-related macular degeneration
err2023-12-19
err3
errOAAI
errHuang, Chengnan; Wang, Yuelin; Huang, Jinliang; Liu, Huiqin; Chen, Zhidong; Jiang, Yang; Chen, Youxin; Qian, Feng
err分享
err收藏
Polymorphic nanobody crystals as long-acting intravitreal therapy for wet age-related macular degeneration
err2023-05-04
err3
errOAAI
errZhu, Shuqian; Fan, Shilong; Tang, Tianxin; Huang, Jinliang; Zhou, Heng; Huang, Chengnan; Chen, Youxin; Qian, Feng
err分享
err收藏
Synergistic autophagy blockade and VDR signaling activation enhance stellate cell reprogramming in pancreatic ductal adenocarcinoma
err2022-07-01
err9
PREAI
errKong, Weijian; Liu, Zhengsheng; Sun, Mengnan; Liu, Huiqin; Kong, Chao; Ma, Jie; Wang, Rui; Qian, Feng
err分享
err收藏
An Elusive Drug-Drug Cocrystal Prepared Using a Heteroseeding Strategy
err2021-09-07
err14
PREAI
errLiu, Chengyu; Wang, Chenguang; Wan, Shan; Liu, Lei; Sun, Changquan Calvin; Qian, Feng
err分享
err收藏

研究方向

胰腺癌的药物设计和递送肿瘤生物学肿瘤免疫微环境胰腺癌白蛋白转运和代谢机制胰腺癌治疗新药和药物递送策略天然产物用于胰腺癌治疗视网膜疾病的药物设计和递送糖尿病性黄斑水肿致盲性视网膜疾病药物分子设计和递送药理活性长效性可注射性蛋白药物结构与生物药剂学性质难溶难吸收药物研究抗体和融合蛋白,等各类药物的药物-药物药物-辅料制剂-生物组织相互作用药物制剂物理稳定性口服生物利用度吸收路径药代动力学物理和生物药剂学性质种类药物-高分子相互作用制剂溶出行为分子药剂学药物递送系统KRAS靶向药物递送策略Theranostics. 202212(3): 1061-1073J Control Release . 2020323(March):311-32013(4):4049-4063Small, 2018 Dec高浓度蛋白的聚集动力学和溶液稳定性机制单抗制剂高浓度胶体溶液稳定性单抗聚集控制产品表观质量下降单抗聚集动力学稳定性机制高浓度蛋白药物制剂胶体科学单抗溶液相分离